Zoetis Inc. (LON: 0M3Q)
London
· Delayed Price · Currency is GBP · Price in USD
166.55
+0.74 (0.45%)
Jan 22, 2025, 7:12 PM BST
Zoetis Revenue
Zoetis had revenue of $2.39B USD in the quarter ending September 30, 2024, with 11.02% growth. This brings the company's revenue in the last twelve months to $9.15B, up 9.33% year-over-year. In the year 2023, Zoetis had annual revenue of $8.54B with 5.74% growth.
Revenue (ttm)
$9.15B
Revenue Growth
+9.33%
P/S Ratio
n/a
Revenue / Employee
$649.08K
Employees
14,100
Market Cap
61.04B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
Dec 31, 2019 | 6.26B | 435.00M | 7.47% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Zoetis News
- 12 days ago - How Is The Market Feeling About Zoetis? - Benzinga
- 15 days ago - Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now? - PRNewsWire
- 15 days ago - Zoetis Inc (ZTS) Announces Upcoming Webcast for Q4 and Full Year 2024 Financial Results - GuruFocus
- 16 days ago - Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 20 days ago - My Top 15 High Growth Dividend Stocks For January 2025 - Seeking Alpha
- 21 days ago - Revisited: does the evidence on glucose tracking add up? – podcast - The Guardian
- 22 days ago - Dividends Matter - 3 Of My Favorite Stocks In An Overpriced Market - Seeking Alpha
- 27 days ago - The Wall Street Journal Vs. Zoetis - Seeking Alpha